Logo for Vaxart Inc

Vaxart Investor Relations Material

Latest events

Logo for Vaxart Inc

Q3 2024

Vaxart
Logo for Vaxart

Q3 2024

13 Nov, 2024
Logo for Vaxart

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Vaxart Inc

Access all reports
Vaxart Inc. is a biotechnology company focused on developing oral vaccines that are administered using tablet formulations rather than injections. The company's proprietary oral vaccine platform is designed to stimulate immune responses in mucosal tissues, which are the first line of defense against many infections. Vaxart's vaccine candidates target a range of infectious diseases, including influenza, norovirus, and COVID-19. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.